Ultragenyx Pharmaceutical | RARE - Дебиторская задолженность





Дебиторская задолженность Изменить Дата
Acadia Pharmaceuticals USD 148.38M 153K 2026-03
Agios Pharmaceuticals USD 16.13M 5.56M 2026-03
Alnylam Pharmaceuticals USD 883.96M 106.39M 2026-03
BioCryst Pharmaceuticals USD 106.82M 15.49M 2025-12
BioMarin Pharmaceutical USD 903.91M 4.3M 2026-03
Esperion Therapeutics USD 140.19M 21.21M 2025-12
Immunic USD 333K 156K 2025-12
Insmed USD 178.55M 37.7M 2026-03
Ionis Pharmaceuticals USD 74M 8M 2026-03
Karyopharm Therapeutics USD 26.18M 5.6M 2025-12
Kyowa Hakko Kirin JPY 120.9B 60.31B 2026-03
MacroGenics USD 13.37M 55.86M 2025-12
Moderna USD 71M 113M 2026-03
Neurocrine Biosciences USD 768.1M 81.3M 2026-03
PTC Therapeutics USD 181.62M 21.45M 2025-12
Puma Biotechnology USD 28.1M 3.52M 2024-06
Regeneron Pharmaceuticals USD 5.73B 10.1M 2026-03
Sarepta Therapeutics USD 547.91M 149.68M 2026-03
Ultragenyx Pharmaceutical USD 60M 98M 2026-03
Vertex Pharmaceuticals USD 2B 56.7M 2026-03
Xoma USD 14.78M 4.96M 2024-06